These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency. Slatter MA; Brigham K; Dickinson AM; Harvey HL; Barge D; Jackson A; Bown N; Flood TJ; Cant AJ; Abinun M; Gennery AR J Allergy Clin Immunol; 2008 Feb; 121(2):361-7. PubMed ID: 18086494 [TBL] [Abstract][Full Text] [Related]
38. [Severe combined immunodeficiency: The time for newborn screening has come]. Hoyos Bachiloglu R; Sotomayor F C; Poli H C Rev Chil Pediatr; 2019 Dec; 90(6):581-588. PubMed ID: 32186580 [TBL] [Abstract][Full Text] [Related]
39. Primary immunodeficiencies: molecular aspects and treatment. Fischer A Bone Marrow Transplant; 1992; 9 Suppl 1():39-43. PubMed ID: 1354525 [No Abstract] [Full Text] [Related]
40. Stem cell transplantation for primary immunodeficiencies: King Faisal Specialist Hospital experience from 1993 to 2006. Al-Ghonaium A Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S53-S56. PubMed ID: 18724302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]